Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide (brand name Mounjaro) and semaglutide represent two distinct classes of injectable weight loss medications, each triggering unique metabolic pathways in the body. Clinical evidence shows tirzepatide produces numerically greater average weight loss than semaglutide across comparable dosing periods, but individual results vary significantly based on genetics, lifestyle, and metabolic factors. Understanding how these medications work differently—and which one may suit your biology—requires looking beyond averages into personalized medicine.

How Tirzepatide and Semaglutide Work Differently

Semaglutide activates one receptor: GLP-1R (glucagon-like peptide-1 receptor). This single-pathway activation slows stomach emptying, reduces hunger signals in the brain, and improves blood sugar control. Millions of patients worldwide have used semaglutide since its FDA approval, building a deep safety database across diverse populations.

Tirzepatide activates two receptors: GLP-1R and GIPR (glucose-dependent insulinotropic polypeptide receptor). By engaging both pathways simultaneously, tirzepatide produces a dual hormone effect. This means it triggers appetite suppression through two separate brain mechanisms while also enhancing insulin secretion and metabolic rate more potently than single-receptor therapies.

The dual-receptor mechanism doesn't guarantee better results for everyone. Some patients respond exceptionally well to semaglutide's focused GLP-1 pathway, while others experience superior weight loss on tirzepatide's combination approach. Genetic variations in these receptor genes influence how effectively each medication works in your specific biology.

Clinical Weight Loss Data: Tirzepatide vs Semaglutide

In the SURMOUNT-1 trial, patients on tirzepatide 15 mg achieved average weight loss of approximately 22% of body weight over 72 weeks. In comparable semaglutide studies (STEP-4), patients at the highest approved dose achieved approximately 17% average body weight reduction. This 5-percentage-point difference represents a meaningful clinical advantage for tirzepatide in population averages, though individual variation can be substantial.

Side-by-side comparisons become less clear when accounting for dropout rates, dosing timelines, and patient-specific factors. Some patients discontinued tirzepatide due to gastrointestinal side effects and showed excellent response to semaglutide instead. Other patients achieved inadequate weight loss on semaglutide despite dose optimization but succeeded dramatically once switching to tirzepatide. This heterogeneity underscores why one-size-fits-all recommendations miss the mark.

Neither medication produces weight loss through a single mechanism. Both reduce caloric intake by suppressing appetite and increasing satiety. Both improve insulin sensitivity. Both may increase resting energy expenditure. The proportional contribution of each mechanism differs between individuals based on metabolic genetics, baseline insulin resistance, and hormonal baseline states.

Why Your Genetics Matter More Than Average Data

Four genetic variants emerge as key predictors of GLP-1 medication response: GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. These variants influence receptor sensitivity, appetite regulation, and fat storage metabolism. A patient with favorable variants in GIPR may experience accelerated response to tirzepatide, while another person with protective FTO variants might achieve sufficient weight loss on lower semaglutide doses.

PlexusDx Precision Peptide Genetic Test maps your individual peptide-pathway profile across 14 metabolic pathways and 49 distinct peptides. This testing (available as a $99 add-on after beginning treatment) goes beyond simple pharmacogenomics to reveal how your genetic architecture predisposes you toward specific medication mechanisms. With this data, PlexusDx clinicians can recommend tirzepatide if your genetics favor dual GLP-1/GIPR activation, or semaglutide if your profile suggests single-pathway responsiveness will optimize results.

Genetic testing cannot predict outcomes with 100% certainty—environmental factors, adherence, sleep quality, and stress also shape results. However, starting with genetically informed medication selection eliminates months of trial-and-error and increases the probability of rapid, sustainable weight loss from your first injection.

Cost, Access, and Personalized Treatment at PlexusDx

PlexusDx compounded tirzepatide injection starts at $249 per month across all three commitment tiers, with pricing that remains flat regardless of your dose escalation. PlexusDx also offers compounded semaglutide injection starting at $149 per month, plus oral formulations and dual-compound options for patients preferring different delivery methods. All medications come from licensed 503A compounding pharmacies and require no insurance, no membership fees, and remain HSA/FSA eligible.

Access to either medication through PlexusDx covers all 50 states without geographic restrictions. Patients begin with an initial consultation to establish baseline health markers, weight loss goals, and medical history. After starting treatment, the optional Precision Peptide Genetic Test can be added ($99) to inform potential medication adjustments or to validate whether your current selection aligns with your genetic profile.

If tirzepatide's clinical superiority in average weight loss appeals to you, PlexusDx makes it financially accessible at $249/month—a significant savings versus brand-name Mounjaro or Zepbound pricing. If semaglutide's longer safety track record and lower cost ($149/month) better fit your preferences, PlexusDx delivers the same compounded-pharmacy quality at transparent, predictable pricing.

Making Your Medication Decision: Tirzepatide, Semaglutide, or Dual Options

Choosing between tirzepatide and semaglutide depends on several overlapping factors: your genetic predisposition (revealed by testing), your baseline metabolic health, your tolerance for gastrointestinal side effects, and your target weight loss timeline. Patients with significant insulin resistance or A1C elevation often benefit from tirzepatide's enhanced insulin secretion. Patients with primarily appetite-driven overeating may respond excellently to semaglutide's focused GLP-1 mechanism.

PlexusDx also offers GLP-Squared Injection, a proprietary dual-compound formulation combining semaglutide and tirzepatide in one dose, starting at $249/month. This option provides patients with both receptor pathways without requiring separate injections, making it ideal for individuals who suspect they need dual activation or who want to experience benefits from both mechanisms within a single treatment protocol.

Your dose may need to go up as your body adapts and weight loss plateaus. Your price won't increase—PlexusDx maintains flat monthly pricing regardless of dose level. This commitment removes the financial barrier to dose optimization, ensuring you receive adequate medication strength to achieve your health goals without budgeting anxiety.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will I lose more weight on tirzepatide than semaglutide?

Clinical trials show tirzepatide produces approximately 5 percentage points more average body weight loss than semaglutide (22% vs 17%), but individual results vary dramatically based on genetics and lifestyle.

What is the clinical difference between a GLP-1 agonist and a dual GLP-1/GIP agonist?

Semaglutide (GLP-1 agonist) activates one appetite-suppression pathway. Tirzepatide (GLP-1/GIP agonist) activates two, producing enhanced appetite reduction, improved insulin secretion, and potentially faster metabolic rate increases.

How much does PlexusDx tirzepatide cost, and does price change with dose increases?

PlexusDx compounded tirzepatide injection starts at $249 per month across all commitment tiers. Your dose may need to go up as you progress—your price won't. Pricing remains flat regardless of dose escalation, and all medications qualify for HSA/FSA benefits with no insurance required.

Are there more side effects with tirzepatide compared to semaglutide?

Both medications commonly cause nausea, constipation, and appetite loss, particularly during dose escalation. Tirzepatide shows a slightly higher frequency of gastrointestinal side effects in trials, though most resolve within weeks. Some patients tolerate tirzepatide better than semaglutide; others experience the reverse.

Can the Precision Peptide Genetic Test predict whether tirzepatide or semaglutide will work better for me?

The PlexusDx Precision Peptide Genetic Test ($99 add-on after first month) analyzes 14 metabolic pathways and 150+ genetic insights, including key variants in GLP1R and GIPR genes.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves